Corpay (CPAY) Lands Fever FX Deal, Is It Still 10% Below Fair Value?
Corpay (CPAY) drew fresh attention after announcing its Cross-Border unit will become the exclusive global foreign exchange partner for Fever, a live entertainment discovery and ticketing platform operating across several major regions.
See our latest analysis for Corpay.
Corpay's latest client win comes as the stock trades at US$353.64, with a 90 day share price return of 12.21% and a 17.65% share price return year to date. The 5 year total shareholder return of 38.58% suggests steadier progress over a longer horizon.
If this Cross Border agreement has you thinking about where else growth stories might be emerging, it could be worth scanning a curated list of 18 top founder-led companies
Corpay now sits at US$353.64 with a recent double digit 90 day gain, yet analyst targets and intrinsic value estimates point higher. How wide is the gap between today’s price and what the stock may be worth?
Most Popular Narrative: 10.5% Undervalued
Corpay's most followed valuation narrative places fair value at $395.14 versus the last close at $353.64, framing the Fever partnership against a wider rerating story.
Corpay's rapid expansion of its international cross-border platform, including product launches like the multicurrency account (MCA), extension of services to new customer verticals (FIs, asset managers, digital asset providers), and accretive acquisitions (e.g., Alpha, GPS) positions the company to capitalize on growing global commerce and cross-border payment flows. This supports sustained revenue growth and increases the company's long-term earnings power.
Want to see what is behind that confidence in Corpay's future cash flows and fair value? The narrative leans on compound revenue gains, fatter margins, and a lower earnings multiple than many investors might expect.
Result: Fair Value of $395.14 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Corpay's story also hinges on managing risks around rising compliance and cybersecurity costs, as well as intense competition that could pressure margins and customer economics.
Find out about the key risks to this Corpay narrative.
Another View: Corpay Through the P/E Lens
While the narrative and fair value estimate suggest Corpay may have upside, the current P/E ratio of 19.7x tells a different story. It sits above the US Diversified Financial industry average of 16x, its peer average of 14.4x, and slightly above a fair ratio of 19.5x, which points to less margin for error if expectations are not met.
This richer P/E profile can be read as investors already paying a premium for Corpay's earnings outlook. This raises the question of whether future results will justify that premium or instead push the ratio closer to the fair ratio over time.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Reading this mix of optimism and caution around Corpay, you may wish to review the underlying figures yourself and decide how comfortable you are with the balance of risks and rewards by checking out the 3 key rewards and 2 important warning signs
Looking for more investment ideas beyond Corpay?
If Corpay has sharpened your interest in what else the market is offering, it makes sense to keep building your watchlist with fresh, well researched ideas.
- Target stronger long term compounding by scanning companies that look mispriced on both quality and valuation using the 45 high quality undervalued stocks
- Strengthen your income stream by reviewing stocks that combine higher yields with resilient payout profiles through the 9 dividend fortresses
- Prioritize resilience by filtering for companies that pair solid balance sheets with steady fundamentals using the solid balance sheet and fundamentals stocks screener (47 results)
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com